Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance Protocol for Nesina® Tablet [Monotherapy or Combination Therapy in Type 2 Diabetic Patients]

NCT04980040 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04980040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04980040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance Protocol for Nesina® Tablet [Monotherapy or Combination Therapy in Type 2 Diabetic Patients]
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
April 19, 2014
Completion date
August 30, 2019
Enrollment
3,623 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus